Novartis AG NVS
Set alert
161.52 USD +0.73 +0.45%
At close · Nov 2
161.52 0.00 0.00%
After hours · Nov 2, 4:01 PM ET
160.11 Day range 161.87
122.86 52-week range 170.46
- YTD
- +17.15%
- 1 year
- +30.48%
- Open
- 160.54
- Prev close
- 160.79
- Mkt cap
- 305.05B
- Vol
- 1.55M
- Avg vol
- 2.05M
- EPS
- 5.26
- P/E
- 30.71
- Div yield
- 2.95%
More statistics
- Low
- 160.11
- High
- 161.87
- Forward P/E
- 16.25
- Beta
- 0.46
- Short ratio
- 3.01
- Inst. own
- 7.30%
- Dividend
- 4.74
- Ex-div date
- Mar 10, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 148.40
- 200-d avg
- 151.81
- 1y target
- 154.80
5D chart
Events in this range
- Oct 27, 2026Earnings: 2.46; estimate 2.25; surprise 9.33%
- Oct 30, 2026Downgrade: Deutsche Bank · Hold → Sell
Signals (129)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 3:50 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 9 hours ago |
| MACD: Sell Signal | Nov 2, 3:25 PM | 9 hours ago |
| RSI: Overbought | Nov 2, 3:00 PM | 9 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 2:25 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 10 hours ago |
| MACD: Sell Signal | Nov 2, 2:20 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 11:50 AM | 12 hours ago |
| SMA: Bearish | Nov 2, 11:40 AM | 12 hours ago |
| SMA: Bullish | Nov 2, 11:35 AM | 13 hours ago |
| SMA: Bullish | Nov 2, 11:20 AM | 13 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 13 hours ago |
| SMA: Bullish | Nov 2, 11:05 AM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 11:00 AM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 10:55 AM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 10:50 AM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 10:20 AM | 14 hours ago |
Newest 20 of 129.
Financial health
Altman Z-Score
3.61 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 2
- P/B 1
Valuation
P/E 19.0×
FY 2016 5y median 16.4× FY 2025
P/S 4.9×
FY 2016 5y median 4.3× FY 2025
P/B 5.8×
FY 2016 5y median 4.5× FY 2025
P/FCF 15.1×
FY 2016 5y median 15.1× FY 2025
EV/EBITDA 12.7×
FY 2016 5y median 12.2× FY 2025
EV/Sales 5.3×
FY 2016 5y median 4.8× FY 2025
FCF Yield 6.6%
FY 2016 5y median 6.6% FY 2025
Profitability
Gross Margin 75.0%
FY 2016 5y median 73.4% FY 2025
Operating Margin 31.2%
FY 2016 5y median 22.9% FY 2025
Net Margin 25.6%
FY 2016 5y median 25.6% FY 2025
ROE 30.5%
FY 2016 5y median 30.5% FY 2025
ROIC 15.5%
FY 2016 5y median 11.5% FY 2025
ROA 12.2%
FY 2016 5y median 12.2% FY 2025
Growth (YoY)
Revenue 6.0%
FY 2016 FY 2025
Operating Income 17.4%
FY 2016 FY 2025
EPS (diluted) 22.5%
FY 2016 FY 2025
Free Cash Flow 28.1%
FY 2016 FY 2025
Financial Health
Current Ratio 1.1×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 0.9×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 0.8×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.1×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 14.4×
FY 2016 5y median 11.2× FY 2025
Dividends
Dividend Yield 2.9%
FY 2016 5y median 3.9% FY 2025
Payout Ratio 55.9%
FY 2016 5y median 55.9% FY 2025
Annual · latest fiscal year ends 2025-12-31
